Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?

Detalles Bibliográficos
Autores principales: Garraud, Olivier, Watier, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Clinical Trial Section (Editorial)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164650/
https://www.ncbi.nlm.nih.gov/pubmed/37169698
http://dx.doi.org/10.1016/j.transci.2023.103726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164650/
https://www.ncbi.nlm.nih.gov/pubmed/37169698
http://dx.doi.org/10.1016/j.transci.2023.103726

Ejemplares similares